Literature DB >> 5650719

[Preventive value of dried dysentery bacteriophage].

E G Babalova, K T Katsitadze, L A Sakvarelidze, N Sh Imnaishvili, T G Sharashidze, V A Badashvili, G P Kiknadze, A N Meĭpariani, N D Gendzekhadze, E V Machavariani, K L Gogoberidze, E I Gozalov, N G Dekanosidze.   

Abstract

Entities:  

Mesh：

Year:  1968        PMID： 5650719

Source DB:  PubMed          Journal:  Zh Mikrobiol Epidemiol Immunobiol        ISSN： 0372-9311


× No keyword cloud information.
  17 in total

Review 1.  Bacteriophage therapy.

Authors:  A Sulakvelidze; Z Alavidze; J G Morris
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

Review 2.  Bacteriophage therapy against Enterobacteriaceae.

Authors:  Youqiang Xu; Yong Liu; Yang Liu; Jiangsen Pei; Su Yao; Chi Cheng
Journal:  Virol Sin       Date:  2015-02-03       Impact factor: 4.327

Review 3.  Bacteriophages and its applications: an overview.

Authors:  Sonika Sharma; Soumya Chatterjee; Sibnarayan Datta; Rishika Prasad; Dharmendra Dubey; Rajesh Kumar Prasad; Mohan G Vairale
Journal:  Folia Microbiol (Praha)       Date:  2016-10-08       Impact factor: 2.099

4.  Phage treatment of human infections.

Authors:  Stephen T Abedon; Sarah J Kuhl; Bob G Blasdel; Elizabeth Martin Kutter
Journal:  Bacteriophage       Date:  2011-03

5.  Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy.

Authors:  Anne Bruttin; Harald Brüssow
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

Review 6.  Bacteriophages and phage-inspired nanocarriers for targeted delivery of therapeutic cargos.

Authors:  Mahdi Karimi; Hamed Mirshekari; Seyed Masoud Moosavi Basri; Sajad Bahrami; Mohsen Moghoofei; Michael R Hamblin
Journal:  Adv Drug Deliv Rev       Date:  2016-03-17       Impact factor: 15.470

Review 7.  Natural solution to antibiotic resistance: bacteriophages 'The Living Drugs'.

Authors:  Sabah A A Jassim; Richard G Limoges
Journal:  World J Microbiol Biotechnol       Date:  2014-04-30       Impact factor: 3.312

8.  Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials.

Authors:  Maya Merabishvili; Jean-Paul Pirnay; Gilbert Verbeken; Nina Chanishvili; Marina Tediashvili; Nino Lashkhi; Thea Glonti; Victor Krylov; Jan Mast; Luc Van Parys; Rob Lavigne; Guido Volckaert; Wesley Mattheus; Gunther Verween; Peter De Corte; Thomas Rose; Serge Jennes; Martin Zizi; Daniel De Vos; Mario Vaneechoutte
Journal:  PLoS One       Date:  2009-03-20       Impact factor: 3.240

9.  Bacteriophages for managing Shigella in various clinical and non-clinical settings.

Authors:  Lawrence D Goodridge
Journal:  Bacteriophage       Date:  2013-05-21

10.  Genome analysis of the staphylococcal temperate phage DW2 and functional studies on the endolysin and tail hydrolase.

Authors:  Ruth Keary; Olivia McAuliffe; R Paul Ross; Colin Hill; Jim O'Mahony; Aidan Coffey
Journal:  Bacteriophage       Date:  2014-03-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.